RNXT RenovoRx, Inc.
USHealthcareAs of 2026-08-17
Why RNXT matters now
RenovoRx, Inc. (RNXT) is a US stock in Healthcare. The latest InvestLog snapshot shows $1.20 with -14.29% on the session and $54.1M in market capitalization; recent performance reads 1-month +14.16% and YTD +9.51%.
The latest financial table shown here is Q1 2026, with revenue of $563.0K, net income of $-3.5M, and EPS of $-0.09. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -33.0%.
The latest indexable market news headline is "RenovoRx Eyes 2027 TIGeR-PaC Readout as RenovoCath Expands to 21 Centers" from MarketBeat.
Additional event context on this page matters because analyst consensus is Buy with a median target of $—; recent insider activity includes VOLL MARK filing P-Purchase. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
3.11
P/S
23.00
EV/EBITDA
-1.80
DCF Value
$0.92
FCF Yield
-33.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
78.7%
Operating Margin
-864.3%
Net Margin
-824.0%
ROE
-138.6%
ROA
-87.9%
ROIC
-105.9%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $563.0K | $-3.5M | $-0.09 |
| Q4 2025 | $238.0K | $-2.9M | $-0.08 |
| FY 2025 | $1.1M | $-11.2M | $-0.32 |
| Q3 2025 | $266.0K | $-2.9M | $-0.08 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
—
Beta
1.00
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced pancreatic cancer. Established in 2009, RenovoRx, Inc. maintains its headquarters in Los Altos, California.